This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Holger Fuchs: Innovator in Eye Disease Treatment
Introduction
Holger Fuchs is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of eye diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Holger Fuchs holds a patent for "Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases." This invention relates to binding molecules that specifically target Vascular Endothelial Growth Factor (VEGF) and Tropomyosin receptor kinase B (TrkB). The patent outlines their use in medicine, pharmaceutical compositions, and methods for treating and preventing diseases of the eye.
Career Highlights
Fuchs is currently associated with Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex medical challenges.
Collaborations
Holger Fuchs collaborates with esteemed colleagues, including Peter Michael Benz and Remko Alexander Bakker. These partnerships enhance the scope and impact of his research.
Conclusion
Holger Fuchs exemplifies the spirit of innovation in the medical field, particularly in the treatment of eye diseases. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile